Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum

Shelly D. Dickinson, Jilla Sabeti, Gaynor A. Larson, Karen Giardina, Marcelo Rubinstein, Michele A. Kelly, David Grandy, Malcolm J. Low, Greg A. Gerhardt, Nancy R. Zahniser

    Research output: Contribution to journalArticle

    186 Citations (Scopus)

    Abstract

    Presynaptic D2 dopamine (DA) autoreceptors, which are well known to modulate DA release, have recently been shown to regulate DA transporter (DAT) activity. To examine the effects of D2 DA receptor deficiency on DA release and DAT activity in dorsal striatum, we used mice genetically engineered to have two (D2(+/+)), one (D2(+/-)), or no (D2(-/-)) functional copies of the gene coding for the D2 DA receptor. In vivo microdialysis studies demonstrated that basal and K+-evoked extracellular DA concentrations were similar in all three genotypes. However, using in vivo electrochemistry, the D2(-/-) mice were found to have decreased DAT function, i.e., clearance of locally applied DA was decreased by 50% relative to that in D2(+/+) mice. In D2(+/+) mice, but not D2(-/-) mice, local application of the D2-like receptor antagonist raclopride increased DA signal amplitude, indicating decreased DA clearance. Binding assays with the cocaine analogue [3H]WIN 35,428 showed no genotypic differences in either density or affinity of DAT binding sites in striatum or substantia nigra, indicating that the differences seen in DAT activity were not a result of decreased DAT expression. These results further strengthen the idea that the D2 DA receptor subtype modulates activity of the striatal DAT.

    Original languageEnglish (US)
    Pages (from-to)148-156
    Number of pages9
    JournalJournal of Neurochemistry
    Volume72
    Issue number1
    DOIs
    StatePublished - 1999

    Fingerprint

    Dopamine Plasma Membrane Transport Proteins
    Dopamine D2 Receptors
    Dopamine
    Raclopride
    Electrochemistry
    Corpus Striatum
    Autoreceptors
    Microdialysis
    Substantia Nigra
    mouse DRD2 protein
    Cocaine
    Assays
    Genes
    Binding Sites
    Genotype

    Keywords

    • D dopamine autoreceptor
    • Dopamine uptake
    • Gene knockout mice
    • In vivo electrochemistry
    • In vivo microdialysis
    • Striatum

    ASJC Scopus subject areas

    • Biochemistry
    • Cellular and Molecular Neuroscience

    Cite this

    Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. / Dickinson, Shelly D.; Sabeti, Jilla; Larson, Gaynor A.; Giardina, Karen; Rubinstein, Marcelo; Kelly, Michele A.; Grandy, David; Low, Malcolm J.; Gerhardt, Greg A.; Zahniser, Nancy R.

    In: Journal of Neurochemistry, Vol. 72, No. 1, 1999, p. 148-156.

    Research output: Contribution to journalArticle

    Dickinson, SD, Sabeti, J, Larson, GA, Giardina, K, Rubinstein, M, Kelly, MA, Grandy, D, Low, MJ, Gerhardt, GA & Zahniser, NR 1999, 'Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum', Journal of Neurochemistry, vol. 72, no. 1, pp. 148-156. https://doi.org/10.1046/j.1471-4159.1999.0720148.x
    Dickinson, Shelly D. ; Sabeti, Jilla ; Larson, Gaynor A. ; Giardina, Karen ; Rubinstein, Marcelo ; Kelly, Michele A. ; Grandy, David ; Low, Malcolm J. ; Gerhardt, Greg A. ; Zahniser, Nancy R. / Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. In: Journal of Neurochemistry. 1999 ; Vol. 72, No. 1. pp. 148-156.
    @article{55d9e1cb62774814b12a6e3bba7c28cf,
    title = "Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum",
    abstract = "Presynaptic D2 dopamine (DA) autoreceptors, which are well known to modulate DA release, have recently been shown to regulate DA transporter (DAT) activity. To examine the effects of D2 DA receptor deficiency on DA release and DAT activity in dorsal striatum, we used mice genetically engineered to have two (D2(+/+)), one (D2(+/-)), or no (D2(-/-)) functional copies of the gene coding for the D2 DA receptor. In vivo microdialysis studies demonstrated that basal and K+-evoked extracellular DA concentrations were similar in all three genotypes. However, using in vivo electrochemistry, the D2(-/-) mice were found to have decreased DAT function, i.e., clearance of locally applied DA was decreased by 50{\%} relative to that in D2(+/+) mice. In D2(+/+) mice, but not D2(-/-) mice, local application of the D2-like receptor antagonist raclopride increased DA signal amplitude, indicating decreased DA clearance. Binding assays with the cocaine analogue [3H]WIN 35,428 showed no genotypic differences in either density or affinity of DAT binding sites in striatum or substantia nigra, indicating that the differences seen in DAT activity were not a result of decreased DAT expression. These results further strengthen the idea that the D2 DA receptor subtype modulates activity of the striatal DAT.",
    keywords = "D dopamine autoreceptor, Dopamine uptake, Gene knockout mice, In vivo electrochemistry, In vivo microdialysis, Striatum",
    author = "Dickinson, {Shelly D.} and Jilla Sabeti and Larson, {Gaynor A.} and Karen Giardina and Marcelo Rubinstein and Kelly, {Michele A.} and David Grandy and Low, {Malcolm J.} and Gerhardt, {Greg A.} and Zahniser, {Nancy R.}",
    year = "1999",
    doi = "10.1046/j.1471-4159.1999.0720148.x",
    language = "English (US)",
    volume = "72",
    pages = "148--156",
    journal = "Journal of Neurochemistry",
    issn = "0022-3042",
    publisher = "Wiley-Blackwell",
    number = "1",

    }

    TY - JOUR

    T1 - Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum

    AU - Dickinson, Shelly D.

    AU - Sabeti, Jilla

    AU - Larson, Gaynor A.

    AU - Giardina, Karen

    AU - Rubinstein, Marcelo

    AU - Kelly, Michele A.

    AU - Grandy, David

    AU - Low, Malcolm J.

    AU - Gerhardt, Greg A.

    AU - Zahniser, Nancy R.

    PY - 1999

    Y1 - 1999

    N2 - Presynaptic D2 dopamine (DA) autoreceptors, which are well known to modulate DA release, have recently been shown to regulate DA transporter (DAT) activity. To examine the effects of D2 DA receptor deficiency on DA release and DAT activity in dorsal striatum, we used mice genetically engineered to have two (D2(+/+)), one (D2(+/-)), or no (D2(-/-)) functional copies of the gene coding for the D2 DA receptor. In vivo microdialysis studies demonstrated that basal and K+-evoked extracellular DA concentrations were similar in all three genotypes. However, using in vivo electrochemistry, the D2(-/-) mice were found to have decreased DAT function, i.e., clearance of locally applied DA was decreased by 50% relative to that in D2(+/+) mice. In D2(+/+) mice, but not D2(-/-) mice, local application of the D2-like receptor antagonist raclopride increased DA signal amplitude, indicating decreased DA clearance. Binding assays with the cocaine analogue [3H]WIN 35,428 showed no genotypic differences in either density or affinity of DAT binding sites in striatum or substantia nigra, indicating that the differences seen in DAT activity were not a result of decreased DAT expression. These results further strengthen the idea that the D2 DA receptor subtype modulates activity of the striatal DAT.

    AB - Presynaptic D2 dopamine (DA) autoreceptors, which are well known to modulate DA release, have recently been shown to regulate DA transporter (DAT) activity. To examine the effects of D2 DA receptor deficiency on DA release and DAT activity in dorsal striatum, we used mice genetically engineered to have two (D2(+/+)), one (D2(+/-)), or no (D2(-/-)) functional copies of the gene coding for the D2 DA receptor. In vivo microdialysis studies demonstrated that basal and K+-evoked extracellular DA concentrations were similar in all three genotypes. However, using in vivo electrochemistry, the D2(-/-) mice were found to have decreased DAT function, i.e., clearance of locally applied DA was decreased by 50% relative to that in D2(+/+) mice. In D2(+/+) mice, but not D2(-/-) mice, local application of the D2-like receptor antagonist raclopride increased DA signal amplitude, indicating decreased DA clearance. Binding assays with the cocaine analogue [3H]WIN 35,428 showed no genotypic differences in either density or affinity of DAT binding sites in striatum or substantia nigra, indicating that the differences seen in DAT activity were not a result of decreased DAT expression. These results further strengthen the idea that the D2 DA receptor subtype modulates activity of the striatal DAT.

    KW - D dopamine autoreceptor

    KW - Dopamine uptake

    KW - Gene knockout mice

    KW - In vivo electrochemistry

    KW - In vivo microdialysis

    KW - Striatum

    UR - http://www.scopus.com/inward/record.url?scp=0032589784&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0032589784&partnerID=8YFLogxK

    U2 - 10.1046/j.1471-4159.1999.0720148.x

    DO - 10.1046/j.1471-4159.1999.0720148.x

    M3 - Article

    C2 - 9886065

    AN - SCOPUS:0032589784

    VL - 72

    SP - 148

    EP - 156

    JO - Journal of Neurochemistry

    JF - Journal of Neurochemistry

    SN - 0022-3042

    IS - 1

    ER -